AzTrials
AzTrials

Gum RecessionMCATTsNCT07453147

Selective Versus Contiguous Connective Tissue Grafts in the Modified Tunnel Technique

A study testing Selective/Segmented graft and Continuous graft in people with Gum Recession, run by Centre Hospitalier Universitaire de Liege at 2 sites in 2 countries.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this study is to evaluate how effective a gum grafting procedure is in treating gum recession that affects several teeth. Gum recession happens when the gum tissue pulls away from the tooth, exposing the roots. The study will look at how the treatment improves gum health, appearance, and function. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Gum Recession
What is being tested?
Selective/Segmented graft and Continuous graft
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
2 sitesin 2 countries
Study dates
1 Sep 2025to 1 Sep 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • ASA I or ASA II
  • Good periodontal health
  • Able to undergo oral surgery
  • Must be 18 years old and older
  • No smoking
  • At least two teeth in the same sector in the maxilla and the right and left mandible (except in the mandibular incisive sector), of which at least 2 are contiguous, with vestibular gingival recessions of type RT 1 of 1-5mm (Cairo et al. 2011)
Show all 9Show fewer
  • An identifiable or restorable cemento-enamel junction (CEJ), with or without the presence of a non-carious cervical lesion (Pini-Prato et al. 2010)
  • Plaque index (O'Leary 1972) and bleeding index (Ainamo et al. 1975) scores of less than 20%
  • Able to give informed consent and have signed the consent forms

Who cannot join

  • Teeth showing recession associated with a carious lesion, restoration or cervical prosthesis involving CEJ
  • Teeth with recession depth >5mm
  • Molars with recessions will be treated but will not be taken into account for the measurements
  • Teeth with recession that have already undergone periodontal surgery
  • Presence of severe tooth malposition, rotation or significant version of the tooth
  • Smoker and ex-smoker
Show all 12Show fewer
  • Patient suffering from a disease affecting the periodontium
  • Patient with clinical signs of active periodontitis
  • Known pregnancy in progress or breastfeeding
  • Contraindication to surgery
  • Conditions or circumstances which would prevent completion of study participation or interfere with analysis of study results, such as history of no-compliance or unreliability
  • Patients deprived of their liberty or under legal protection

Trial locations and contacts

2 sites in 2 countries. Contact the study team or a site near you to ask about taking part.

2 sites in 2 countries

Belgium1 site, 1 recruiting
  • CHU de Liège

    Liège, Liège, 4000

    Zacharenia Zoi ZAFEIRIADOU, MsC, +32 4 323 54 27, uperio@chuliege.be

    Recruiting

Other trials in Belgium

France1 site, 1 recruiting
  • 26K Center for clinical research

    Paris, 75116

    Sofia Aroca, PhD, 0033139733434, 26kparis@26kparis.com

    Not yet recruiting

Other trials in France

About this study

Official title: Evaluation of the Modified Coronally Advanced Tunnel Technique Associated With a Selective/Segmented Versus Contiguous Submerged Connective Tissue Graft for the Treatment of Multiple Gingival Recessions: Randomised Controlled Clinical Trial

The goal of this study is to evaluate how effective a gum grafting procedure is in treating gum recession that affects several teeth. Gum recession happens when the gum tissue pulls away from the tooth, exposing the roots. The study will look at how the treatment improves gum health, appearance, and function.

A total of 32 patients will take part in the study. All patients will be treated with a modified coronally advanced tunnel. For half of them of contiguous graft will be used, for the other half a segmented graft.

Read more

Data collected will include medical history, dental and aesthetic information, clinical measurements, and a digital scan of the mouth.

The study will include the following steps:

Before the procedure: You will have a clinical and X-ray examination to determine how much your gums have receded. A digital impression of your teeth will also be taken.

Surgical procedure: You will receive a gum graft to cover the exposed roots. This involves moving gum tissue, often taken from the roof of your mouth, to the affected areas.

After the procedure: You will have several follow-up visits over a few months to check your healing and the results of the treatment.

Study timeline:

The surgery will be done once. Follow-up visits will take place 1, 3, 6, and 12 months after the surgery. The total duration of the study is about 12 months.

Conditions
Gum Recession
Being tested
Selective/Segmented graft, Continuous graft
Keywords
Gum recession, Recession treatment, Tunnel technique, Connective tissue graft, Gingival recession
Medical subject headings
Gingival Recession

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Selective/Segmented graftProcedure or surgery

    In this group a segmented CTG will be used

  • Continuous graftProcedure or surgery

    In this group a continuous CTG will be used

Study groups in NCT07453147
Study groupRoleWhat they receive
Selective/Segmented graftExperimentalIn this group a segmented CTG will be used
Receives: Procedure: Selective/Segmented graft
Continuous graftActive comparatorIn this group a continuous CTG will be used
Receives: Procedure: Continuous graft

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Digital complete root coverage

    defined as the presence/absence of complete coverage of the recession at the mid-buccal aspect. It will be evaluated by taking the CEJ as a reference line, at the different timepoints, analysed digitally using the digital impression

    Measured: 3, 6 and 12 months

Secondary outcomes (11)
  1. Complete Root Coverage

    defined as the presence/absence of complete coverage of the recession at the mid-buccal aspect. It will be evaluated by taking the CEJ as a reference line, at the different timepoints.

    Measured: 3, 6 and 12 months

  2. Mean Root Coverage

    defined as the percentage of root coverage in the mid-buccal aspect, taking baseline as a refer-ence. It equals to difference of the linear distance (in mm, using probe) between the mid-buccal point of the CEJ and the mid-buccal margin at baseline and different timepoints, divided by the distance between the mid buccal point of the CEJ and the mid buccal margin at baseline. The MRC will be measured as percentage (%).

    Measured: 3, 6 and 12 months

  3. Keratinized Tissue Height

    Defined as the linear height of keratinized tissue, measured between the mid-buccal gingival mar-gin of the treated tooth and the muco-gingival junction (in mm using a probe). It will be measured at baseline and at the different timepoints.

    Measured: 3, 6 and 12 months

  4. Recession reduction

    defined as the linear reduction in recession (in mm using a probe), at the mid buccal aspect, be-tween baseline and the different timepoints. It will be measured at the different timepoints.

    Measured: 3, 6 and 12 months

  5. Dental hypersensitivity

    Assessed by 10 s air spray applied to the buccal cervical area (yes/no).

    Measured: 3, 6 and 12 months

  6. Root-coverage Esthetic Score

    Evaluated at the different timepoints according to Cairo et al. (2009).

    Measured: 3, 6 and 12 months

  7. Digital mean root coverage

    Defined as the percentage of root coverage in the mid-buccal aspect, taking baseline as a refer-ence. Measured by dividing the mean surface (in mm²) of the root covered by the procedure by the mean surface (in mm²) of root exposed at baseline. Measured digitally at 3-6 months and 1 year after surgery.

    [(Initial Exposed Root Surface(mm2) - Post-operative exposed root surface(mm2)) / Initial Exposed Root Surface(mm2)] x 100%.

    Measured: 3, 6 and 12 months

  8. Digital recession reduction

    defined as the reduction in recession (in mm², measured digitally), at the mid-buccal aspect, be-tween baseline and the different timepoints. It will be measured at the different timepoints.

    Measured: 3, 6 and 12 months

  9. Digital Gingival soft tissues profile

    Defined as the change in gingival soft tissue thickness between baseline and the different timepoints, measured at the mid buccal aspect, between baseline and the different timepoints tak-ing CEJ as reference.

    Measured: 3, 6 and 12 months

  10. Volumetric Changes

    evaluated as 3D changes in the volume of gingival tissue between different timepoints, measured using the digital impression.

    Measured: 3, 6 and 12 months

  11. Patient Reported Outcome Measures

    Self-perceived pain: Reported on a 100mm VAS scale ranging from 0 (no pain at all) to 100 (worst pain possible).

    Number, nature and frequency of medication: Patients will be asked to report every take of medica-tion (substance, posology, and time of the day).

    Swelling: Reported on a 100 mm VAS scale ranging from 0 (no swelling at all) to 100 (worst swelling possible). T Bleeding: Reported on a 100 mm VAS scale ranging from 0 (no bleeding at all) to 100 (worst bleed-ing possible).

    Discomfort during surgery: Reported on a 100 mm VAS scale ranging from 0 (no discomfort at all) to 100 (a lot of discomfort).

    Self-perceived hypersensitivity Aesthetic outcome (self-evaluation): Reported on a 100 mm VAS scale ranging from 0 (no not satis-fied at all) to 100 (best outcome they could imagine).

    Report other adverse effects/ complications

    Measured: 1, 2, 3, 4, 5, 6, 7, 14 days and 3, 6, 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Mar 2026
  2. Study start1 Sep 2025
  3. Primary completion1 Sep 2028 (estimated)
  4. Study completion1 Sep 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
32 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07453147
Sponsor's protocol ID
B7072025000052
Acronym
MCATTs
Status last verified
Mar 2026
First submitted
14 Dec 2025
Last updated
5 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Selective/Segmented graft and Continuous graft in people with Gum Recession, run by Centre Hospitalier Universitaire de Liege at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Belgium, France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Digital complete root coverage (time frame: 3, 6 and 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in